Home NDC 70010-187-03 LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE
Product NDC 70010-187
Requested package NDC 70010-187-03
11-digit product format 700100187
Labeler code 70010
Product ID 70010-187_5d4eea9c-3657-5f79-e063-6294a90a58b7
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE
Dosage form TABLET, FILM COATED
Route ORAL
Labeler Granules Pharmaceuticals Inc.
Application ANDA218015
Marketing category ANDA
Marketing start 2023-09-29
Substance LOSARTAN POTASSIUM; HYDROCHLOROTHIAZIDE
Active strength 50; 12.5 mg/1; mg/1
Pharmacologic classes Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 45 .
Orange Book products# Current product rows page 1 of 1 · 3 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A218015-001 LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM 12.5MG;50MG TABLET / ORAL 2023-09-29 A218015-002 LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM 12.5MG;100MG TABLET / ORAL 2023-09-29 A218015-003 LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM 25MG;100MG TABLET / ORAL 2023-09-29
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 72 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-11-14 07:37:17 2026-10 A218015-001 LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE 12.5MG;50MG TABLET / ORAL 2023-09-29 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 A218015-002 LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE 12.5MG;100MG TABLET / ORAL 2023-09-29 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 A218015-003 LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE 25MG;100MG TABLET / ORAL 2023-09-29 d4dbc9d85df4…2026-10-15 13:18:30 2026-09 A218015-001 LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE 12.5MG;50MG TABLET / ORAL 2023-09-29 c2088c7a36db…2026-10-15 13:18:30 2026-09 A218015-002 LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE 12.5MG;100MG TABLET / ORAL 2023-09-29 c2088c7a36db…2026-10-15 13:18:30 2026-09 A218015-003 LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE 25MG;100MG TABLET / ORAL 2023-09-29 c2088c7a36db…2026-09-14 22:38:34 2026-08 A218015-001 LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE 12.5MG;50MG TABLET / ORAL 2023-09-29 84e616aacf4f…2026-09-14 22:38:34 2026-08 A218015-002 LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE 12.5MG;100MG TABLET / ORAL 2023-09-29 84e616aacf4f…2026-09-14 22:38:34 2026-08 A218015-003 LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE 25MG;100MG TABLET / ORAL 2023-09-29 84e616aacf4f…2026-08-18 06:07:40 2026-07 A218015-001 LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE 12.5MG;50MG TABLET / ORAL 2023-09-29 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A218015-002 LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE 12.5MG;100MG TABLET / ORAL 2023-09-29 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A218015-003 LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE 25MG;100MG TABLET / ORAL 2023-09-29 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A218015-001 LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE 12.5MG;50MG TABLET / ORAL 2023-09-29 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A218015-002 LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE 12.5MG;100MG TABLET / ORAL 2023-09-29 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A218015-003 LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE 25MG;100MG TABLET / ORAL 2023-09-29 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A218015-001 LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE 12.5MG;50MG TABLET / ORAL 2023-09-29 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A218015-002 LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE 12.5MG;100MG TABLET / ORAL 2023-09-29 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A218015-003 LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE 25MG;100MG TABLET / ORAL 2023-09-29 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A218015-001 LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE 12.5MG;50MG TABLET / ORAL 2023-09-29 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A218015-002 LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE 12.5MG;100MG TABLET / ORAL 2023-09-29 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A218015-003 LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE 25MG;100MG TABLET / ORAL 2023-09-29 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A218015-001 LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE 12.5MG;50MG TABLET / ORAL 2023-09-29 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A218015-002 LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE 12.5MG;100MG TABLET / ORAL 2023-09-29 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A218015-003 LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE 25MG;100MG TABLET / ORAL 2023-09-29 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A218015-001 LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE 12.5MG;50MG TABLET / ORAL 2023-09-29 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A218015-002 LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE 12.5MG;100MG TABLET / ORAL 2023-09-29 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A218015-003 LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE 25MG;100MG TABLET / ORAL 2023-09-29 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A218015-001 LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE 12.5MG;50MG TABLET / ORAL 2023-09-29 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A218015-002 LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE 12.5MG;100MG TABLET / ORAL 2023-09-29 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A218015-003 LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE 25MG;100MG TABLET / ORAL 2023-09-29 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A218015-001 LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE 12.5MG;50MG TABLET / ORAL 2023-09-29 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A218015-002 LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE 12.5MG;100MG TABLET / ORAL 2023-09-29 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A218015-003 LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE 25MG;100MG TABLET / ORAL 2023-09-29 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A218015-001 LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE 12.5MG;50MG TABLET / ORAL 2023-09-29 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A218015-002 LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE 12.5MG;100MG TABLET / ORAL 2023-09-29 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A218015-003 LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE 25MG;100MG TABLET / ORAL 2023-09-29 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A218015-001 LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE 12.5MG;50MG TABLET / ORAL 2023-09-29 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A218015-002 LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE 12.5MG;100MG TABLET / ORAL 2023-09-29 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A218015-003 LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE 25MG;100MG TABLET / ORAL 2023-09-29 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A218015-001 LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE 12.5MG;50MG TABLET / ORAL 2023-09-29 d06236e962d9…
Observed Orange Book normalized TE history# Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength LOSARTAN POTASSIUM 50 mg/1 HYDROCHLOROTHIAZIDE 12.5 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 2 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 3ST302B24A Internal UNII lookup 0J48LPH2TH Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 3 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 979464 Internal RxNorm lookup 979468 Internal RxNorm lookup 979471 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 70010-187-03 LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE 30 in 1 BOTTLE TABLET, FILM COATED 30 2 70010-187-10 LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE 1000 in 1 BOTTLE TABLET, FILM COATED 1000 2
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 70010-187 LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE TABLET, FILM COATED [GRANULES PHARMACEUTICALS INC.] 1 Current NDC, 2 package rows 20231013_b4168479-09ec-402c-89cc-456bc8485017.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Sample Exclude flag Status 70010-187-03 70010018703 30 TABLET, FILM COATED in 1 BOTTLE (70010-187-03) 2023-09-29 No No Current